Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02001337 · ClinicalTrials.gov registry record
Examination of the Pancreas in New-onset Diabetes
A clinical trial, sponsored by Mayo Clinic.
- Completed
- Registry status
- 79
- Enrollment target
NCT02001337: Completed study, sponsored by Mayo Clinic.
NCT02001337 is a clinical trial that has completed, run by Mayo Clinic. The registered enrollment target is 79 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02001337 has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- 79 participants
- Enrollment target
Study Summary
The purpose of this study is to create a prospective cohort of subjects with increased probability of being diagnosed with pancreatic cancer and then screen this cohort for pancreatic cancer
Primary Outcome
We will prospectively identify patients with newly diagnosed diabetes and perform pancreatic imaging to identify pancreatic cancer
Interventions
- OTHER medical chart review
- OTHER Specimen collection
- OTHER survey administration
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 79 participants |
| Start Date | 2013-05 |
| Est. Completion | 2016-11-30 |
What the finished NCT02001337 record still lists
NCT02001337 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 79 participants, a relatively small participant target.
The record links to 0 conditions, and to 3 interventions - of which medical chart review is the first listed.
NCT02001337 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02001337 about?
NCT02001337 is a clinical study titled "Examination of the Pancreas in New-onset Diabetes". The purpose of this study is to create a prospective cohort of subjects with increased probability of being diagnosed with pancreatic cancer and then screen this cohort for pancreatic cancer
What is the current status of trial NCT02001337?
This trial is currently completed. The enrollment target is 79 participants. The study started on 2013-05. Estimated completion is 2016-11-30.
What interventions are being tested in trial NCT02001337?
The interventions under investigation include: medical chart review (OTHER), Specimen collection (OTHER), survey administration (OTHER).
Who is sponsoring clinical trial NCT02001337?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05798897 · 79 participants · Phase 1
Safety and Preliminary Efficacy of MT-601 in Patients With Relapsed/Refractory Lymphoma
- NCT06042439 · 79 participants · NA
AM vs PM Exercise Training
- NCT06223555 · 79 participants · NA
Variability In Mixed Meal Tests: Fixed Versus Adjusted to Energy Needs Caloric Dose
- NCT01243931 · 80 participants · NA
Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia